CARDIOVASCULAR

De-risking drug and device development

LSE Investigators: Elias Mossialos; Huseyin Naci
Start Date: 01 November 2024
End Date: 31 October 2027
Region(s): UK
Funder: NIHR
Keywords: Cardiovascular Regulation, Cardiovascular Disease Treatements, Health Systems

Pharmaceutical research and development (R&D) in cardiovascular diseases is hibernating. This research collaboration between the LSE and UCL will tackle high failure rates in R&D in cardiovascular disease. It will evaluate the economic, regulatory, and health system factors driving drug development in cardiovascular disease.

In addition to the research, UCLH staff and LSE faculty and researchers will also jointly convene stakeholder events to increase impact and dissemination.